Annual Report 2021
A year in review
2021 has been a year filled with challenges, but also one during which we have made encouraging advances. Thanks to the hard work and unfailing professionalism of our teams, we continue to pioneer and launch new treatments which will significantly improve our patients’ lives.
Dermatology Innovation and Investment
We have our eyes firmly set on the future as we continue to build upon our portfolio, strengthening our position in the field of medical dermatology. During 2021, we invested more than €73 million euros into our R&D projects. This has enabled us to continue to develop innovative medical solutions which will improve patients’ lives on a daily basis and also positively impact healthcare professionals across the world.
To download the 2021 Annual Report
PDF 12.5MB
Interviews
Driving our R&D
- €73.6m in R&D investment
- R&D : 9% of net sales
Environment
- CO₂ emissions (Scope 1 & 2, location-based): 11,458 tonnes (-10% vs 2020)
- Waste management: 5,390 tonnes (-4% vs 2020)
- CDP climate change score in 2021: B (management level)
Social
1,7861,786
Number of employees
01,786
Number of employees
0%53%
Women
0%47%
Men
026
Nationalities represented
019,297
Total training hours
Net sales by geographic area
82%82%
Europe
0%82%
Europe
0%11%
US
0%7%
Rest of the world